Iress 2025 Results Investor Presentation

Open PDF
Stock Iress Ltd (IRE.ASX)
Release Time 25 Feb 2026, 8:12 a.m.
Price Sensitive Yes
 Iress 2025 Results Investor Presentation
Key Points
  • Headline Adjusted EBITDA $136.2m & UPAT $73.9m
  • Building a leading Wealth and Trading & Market Data software business
  • Simplified business with sharpened strategic focus
Full Summary

Iress delivered strong FY25 financial results, with Adjusted EBITDA of $136.2m and UPAT of $73.9m, ahead of guidance. The company has simplified its business and sharpened its strategic focus on its core Wealth and Trading & Market Data software offerings. Revenue grew 6.5% and Adjusted EBITDA increased 14.9%, with improving second half momentum positioning Iress well for FY26. The company resumed dividends with a final dividend of 13.0 cps, fully franked, and strengthened its balance sheet following the divestment of the Superannuation and QuantHouse businesses. Iress' Continuing Business, comprising APAC Wealth, GTMD (including South Africa and Canada) and UK Wealth & Sourcing, delivered robust performance with revenue growth of 6.5% and Adjusted EBITDA growth of 14.9%. The company successfully executed on key operational initiatives, including the delivery of the ASX Single Open platform and a significant implementation program with a key UK client. Iress is focused on driving operational excellence, client-first execution, modular modernisation and commercial discipline to deliver a FY26 +25% Cash EBITDA exit run-rate through disciplined execution and improved efficiencies.

Guidance

For FY26, Iress expects revenue of $520 - $528 million (3-5% vs FY25), Cash EBITDA of $116 - $123 million (15-23% vs FY25) and UPAT of $84 - $90 million (15-24% vs FY25). The company is targeting a FY26 Cash EBITDA margin exit run-rate of +25%.

Outlook

Iress is focused on driving operational excellence, client-first execution, modular modernisation and commercial discipline to deliver a FY26 +25% Cash EBITDA exit run-rate through disciplined execution and improved efficiencies. The company is well positioned as a high quality, cash compounding software business with meaningful valuation upside.